| Name | Title | Contact Details |
|---|
Whimet Inc is a Warsaw, IN-based company in the Business Services sector.
We craft technology solutions like an Italian grandmother crafts her pesto — with passion, care, and the finest of ingredients. Admittedly, Nonnas pesto tastes much better than anything we create, but our products are guaranteed fresh and made to withstand the test of time. Our subsidiary, Pesto Softworks, engineers affordable, user-friendly software for the LBM industry that automates many routine business operations and improves the business performance of hardware and building supply stores. Thats just one example of what we bring to the plate. Simply put, if you have a technology challenge, were like youre Nonna cooking a holiday dinner, we guarantee satisfaction. And also like Nonna, our creations are crafted to ensure the best experience – beautifully architected, designed, and served.
SmartSoC Solutions Pvt Ltd is a global product engineering company founded in 2016, specializing in semiconductor, embedded systems, artificial intelligence, and automotive technologies. With over 1,250 scientists and engineers, the company operates in multiple countries, including India, the USA, Sweden, and Israel. SmartSoC Solutions offers a wide range of engineering services, including semiconductor design, embedded systems development, AI and data science, IoT solutions, and automotive engineering. They provide end-to-end solutions from silicon design to system-level product engineering, supporting clients throughout the product lifecycle. The company emphasizes innovation, engineering excellence, and cost-effective productization, catering to various industries, particularly semiconductor and technology firms. Their commitment to quality and collaboration drives their mission to deliver intelligent solutions to clients worldwide.
TIXiMED, Inc. is focused on developing and commercializing TXNIP inhibiting medication as a first-of-its-kind oral therapeutic for Type 1 and Type 2 diabetes. TIXiMED is the exclusive license holder for the patent (composition of matter and method of use) surrounding TIX100, a novel small molecule that normalizes pancreatic beta cell TXNIP, a detrimental protein elevated in Type 1 and Type 2 diabetes. Increased TXNIP causes pancreatic islet dysfunction and death of insulin-producing beta cells and thereby contributes to the development and progression of diabetes. Diabetes affects more than half a billion people worldwide. Those affected by Type 1 diabetes are dependent on multiple daily insulin injections or continuous insulin infusions to stay alive and manage their blood sugar. Oral anti-diabetic drugs are only approved for Type 2 diabetes, but can be associated with multiple side effects, underlining the need for novel and better oral diabetes medications for Type 1 and Type 2 diabetes. TXNIP inhibition has recently been demonstrated to be an effective and safe therapeutic approach in adults and children with recent onset Type 1 diabetes and TIX100 shows beneficial, anti-diabetic effects in 4 different mouse models. Advantages of TIX100 include oral availability, no associated hypoglycemia or weight gain, potent inhibition of detrimental TXNIP in human islets, and a favorable pharmacokinetic and safety profile. In addition, TIX100 inhibits excessive glucagon secretion and hepatic glucose production and protects against fatty liver. Thus, TIX100 holds promise for durable, weight-neutral improvement in glycemic control in Type 1 and Type 2 diabetes by targeting common underlying pathology and promoting patients own islet cell health.
The first open-source notification infrastructure for developers. We focus on making tools to support and empower developers, building everything with the open-source community. We see ourselves as a part from the community, as such we happily invest and help others to maintain their open-source project, as well as help others join this amazing community. Join Notifire, join the community.